Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies

CD47 is a ubiquitously expressed immune checkpoint receptor that is often upregulated in cancer. CD47 interacts with its counter-receptor SIRPα on macrophages and other myeloid cells to inhibit cancer cell phagocytosis and drive immune evasion. To overcome tolerability and “antigen sink” issues aris...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Ther
Main Authors: Dheilly, Elie, Moine, Valéry, Broyer, Lucile, Salgado-Pires, Susana, Johnson, Zoë, Papaioannou, Anne, Cons, Laura, Calloud, Sébastien, Majocchi, Stefano, Nelson, Robert, Rousseau, François, Ferlin, Walter, Kosco-Vilbois, Marie, Fischer, Nicolas, Masternak, Krzysztof
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Gene & Cell Therapy 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5368402/
https://ncbi.nlm.nih.gov/pubmed/28153099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2016.11.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados